A global clinical trial has shown promising results for upadacitinib, an arthritis drug, in treating severe alopecia areata. The study, published in JAMA Dermatology, involved patients who had lost a significant amount of scalp hair due to this autoimmune condition. Within 24 weeks, approximately half of the participants taking upadacitinib experienced substantial hair regrowth, with some regaining up to 80% of their scalp hair. AI
RANK_REASON Publication of clinical trial results for a drug's efficacy in treating a specific medical condition. [lever_c_demoted from research: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →